🔎 Trials Near Me

Akèy › Kansè Ezofajyen › Michigan › Detroit

Etid klinik pou Kansè Ezofajyen nan Detroit, MI

9 etid pou Kansè Ezofajyen ap chèche patisipan nan sit nan ak bò kote Detroit (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Vanguard Study: Testing a New Way to Screen for Cancer

Ap rekriteVolontè an sante akeyi
  • Henry Ford Hospital, Detroit
  • Henry Ford Medical Center - Detroit Northwest, Detroit
Laj 45 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06995898

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Ap rekriteVolontè an sante akeyi
  • Henry Ford Health Saint John Hospital, Detroit
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Henry Ford Hospital, Detroit
  • Henry Ford Health Saint John Hospital, Detroit
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Ap rekriteFaz 1
  • Barbara Ann Karmanos Cancer Institute, Detroit
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Ap rekriteFaz 1
  • Barbara Ann Karmanos Cancer Institute, Detroit
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213791

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Ap rekriteFaz 1
  • Karmanos Cancer Institiute, Detroit
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Karmanos Cancer Institute, Detroit
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

Ap rekriteFaz 1
  • Henry Ford Cancer-Detroit, Detroit
Laj 18 ak plis · Tout sèks · Mizajou Dec 19, 2025 · NCT06065371

A Beta-only IL-2 ImmunoTherapY Study

Ap rekriteFaz 1/2
  • Karmanos Cancer Institute, Detroit
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2025 · NCT05086692

Etid Kansè Ezofajyen nan lòt vil

Lòt etid nan Detroit

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.